Journal of Virus Eradication (Dec 2017)
The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial
- J. Symons,
- S.F.L. van Lelyveld,
- W. de Spiegelaere,
- A.M.J. Wensing,
- J. Drylewicz,
- A.I.M. Hoepelman,
- P.U. Cameron,
- H. Lu,
- T. Mota,
- A.I. Dantanarayana,
- L. Vandekerckhove,
- S.R. Lewin,
- K. Tesselaar,
- M. Nijhuis
Affiliations
- J. Symons
- Department of Medical Microbiology, Virology, University Medical Centre Utrecht, Utrecht, the Netherlands; Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia
- S.F.L. van Lelyveld
- Department of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht, Utrecht, the Netherlands
- W. de Spiegelaere
- Department of Internal Medicine, Ghent University, Ghent, Belgium
- A.M.J. Wensing
- Department of Medical Microbiology, Virology, University Medical Centre Utrecht, Utrecht, the Netherlands
- J. Drylewicz
- Department of Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands
- A.I.M. Hoepelman
- Department of Internal Medicine and Infectious Diseases, University Medical Centre Utrecht, Utrecht, the Netherlands
- P.U. Cameron
- Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia
- H. Lu
- Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia
- T. Mota
- Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia
- A.I. Dantanarayana
- Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia
- L. Vandekerckhove
- Department of Internal Medicine, Ghent University, Ghent, Belgium
- S.R. Lewin
- Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia; Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, Australia
- K. Tesselaar
- Department of Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands
- M. Nijhuis
- Department of Medical Microbiology, Virology, University Medical Centre Utrecht, Utrecht, the Netherlands
- Journal volume & issue
-
Vol. 3
p. 42
